455 related articles for article (PubMed ID: 25205766)
1. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
2. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
[TBL] [Abstract][Full Text] [Related]
3. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
4. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression.
Hassan MH; Salama SA; Arafa HM; Hamada FM; Al-Hendy A
J Clin Endocrinol Metab; 2007 Oct; 92(10):3949-57. PubMed ID: 17635941
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
8. Growth factors and cytokines in uterine leiomyomas.
Andersen J
Semin Reprod Endocrinol; 1996 Aug; 14(3):269-82. PubMed ID: 8885057
[TBL] [Abstract][Full Text] [Related]
9. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
[TBL] [Abstract][Full Text] [Related]
11. High aromatase expression in uterine leiomyoma tissues of African-American women.
Ishikawa H; Reierstad S; Demura M; Rademaker AW; Kasai T; Inoue M; Usui H; Shozu M; Bulun SE
J Clin Endocrinol Metab; 2009 May; 94(5):1752-6. PubMed ID: 19240151
[TBL] [Abstract][Full Text] [Related]
12. The role of progesterone signaling in the pathogenesis of uterine leiomyoma.
Kim JJ; Sefton EC
Mol Cell Endocrinol; 2012 Jul; 358(2):223-31. PubMed ID: 21672608
[TBL] [Abstract][Full Text] [Related]
13. Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.
Tanioka S; Asano R; Wakabayashi R; Hayashi H; Shigeta H
BMC Womens Health; 2022 Aug; 22(1):346. PubMed ID: 35974345
[TBL] [Abstract][Full Text] [Related]
14. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism.
Sumitani H; Shozu M; Segawa T; Murakami K; Yang HJ; Shimada K; Inoue M
Endocrinology; 2000 Oct; 141(10):3852-61. PubMed ID: 11014242
[TBL] [Abstract][Full Text] [Related]
15. Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells.
Hodges LC; Houston KD; Hunter DS; Fuchs-Young R; Zhang Z; Wineker RC; Walker CL
Mol Cell Endocrinol; 2002 Oct; 196(1-2):11-20. PubMed ID: 12385821
[TBL] [Abstract][Full Text] [Related]
16. Role of stem cells in human uterine leiomyoma growth.
Ono M; Qiang W; Serna VA; Yin P; Coon JS; Navarro A; Monsivais D; Kakinuma T; Dyson M; Druschitz S; Unno K; Kurita T; Bulun SE
PLoS One; 2012; 7(5):e36935. PubMed ID: 22570742
[TBL] [Abstract][Full Text] [Related]
17. Pathology and pathophysiology of uterine smooth-muscle tumors.
Robboy SJ; Bentley RC; Butnor K; Anderson MC
Environ Health Perspect; 2000 Oct; 108 Suppl 5():779-84. PubMed ID: 11035982
[TBL] [Abstract][Full Text] [Related]
18. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.
Kim JJ; Kurita T; Bulun SE
Endocr Rev; 2013 Feb; 34(1):130-62. PubMed ID: 23303565
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
Nowak RA
Environ Health Perspect; 2000 Oct; 108 Suppl 5():849-53. PubMed ID: 11035994
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of uterine leiomyoma.
Sabry M; Al-Hendy A
Reprod Sci; 2012 Apr; 19(4):339-53. PubMed ID: 22378865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
